- Home
- SLS vs ONCH Comparison
SLS vs ONCH Comparison
Compare SLS & ONCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.03
Company Overview
Basic Information| Metric | SLS | ONCH |
|---|---|---|
| Founded | 2012 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.0M | 223.4M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | SLS | ONCH |
|---|---|---|
| Price | $2.03 | $10.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 4.4M | 40.3K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.77 | $10.16 |
| 52 Week High | $2.48 | $10.63 |
Technical Indicators
Market Signals| Indicator | SLS | ONCH |
|---|---|---|
| Relative Strength Index (RSI) | 66.47 | N/A |
| Support Level | $1.39 | N/A |
| Resistance Level | $2.00 | N/A |
| Average True Range (ATR) | 0.14 | 0.00 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 89.73 | 0.00 |
Price Performance
Historical Comparison SLS
ONCH
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About ONCH 1RT Acquisition Corp. Class A Ordinary Share
1RT Acquisition Corp is a blank check company.